Mereo BioPharma Group plc (LON:0A9G)
0.3929
-0.0188 (-4.56%)
At close: Feb 11, 2026
Mereo BioPharma Group Revenue
Mereo BioPharma Group had revenue of $500.00K USD in the twelve months ending September 30, 2025, down -50.00% year-over-year.
Revenue (ttm)
$500.00K
Revenue Growth
-50.00%
P/S Ratio
122.07
Revenue / Employee
$13.89K
Employees
36
Market Cap
45.41M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 10.00M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 49.37M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BATM Advanced Communications | 86.72M |
| LendInvest | 48.60M |
| Time Finance | 37.76M |
| Palace Capital | 9.18M |
| Life Settlement Assets | 5.00M |
| Ferro-Alloy Resources | 3.74M |
| Schroder BSC Social Impact Trust | 2.19M |
| RM Infrastructure Income | -293.00K |